However, the absence of ILC2s in these mice did not affect the mice survival following bladder tumor challenge, in line with the results obtained when blocking IL-4/IL-13 or IL-5 signaling pathways, or IL-33/ST2 axis. The gene discussed is IL5; the disease is urinary bladder neoplasm.